OpenAlex
PricingAboutJobs
Log inGet started
Work

Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation

HTML PDF

Year: 2015
Type: review
Study designs: Systematic Review, Meta-Analysis
Source: Journal of the American College of Cardiology
DOI: 10.1016/j.jacc.2015.01.039
Authors: Gennaro Giustino, Usman Baber, Samantha Sartori, Roxana Mehran, Ioannis Mastoris, Annapoorna S. Kini, Samin K. Sharma, Stuart J. Pocock, George D. Dangas
Institutions: Icahn School of Medicine at Mount Sinai, London School of Hygiene & Tropical Medicine
Language: English

Topic: Antiplatelet Therapy and Cardiovascular Diseases
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: dual antiplatelet therapy, drug-eluting stents, stent thrombosis, clinically significant bleeding, all-cause mortality, second-generation drug-eluting stents, first-generation drug-eluting stents, antiplatelet therapy duration, percutaneous coronary intervention, coronary artery disease, randomized controlled trials meta-analysis, bleeding risk stratification
SDG: Good health and well-being

Open Access status: bronze

Funders: Amgen, Pfizer, AstraZeneca, GlaxoSmithKline, Edwards Lifesciences, Boston Scientific Corporation, Medicines Company, Biosensors International Group, Janssen Pharmaceuticals
OpenAlex ID: W2022895464
FWCI: 11.34
Cites: 35
Cited by: 367
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms